Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MYM Nutraceuticals Inc MYMMF

Healthcare Drug Manufacturers - Major
MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.


GREY:MYMMF - Post by User

MYM Nutraceuticals Inc
Bullboard Posts
User Avatar Image
(3)
•••
Comment by WeeblesWobbleon Jan 14, 2019 5:45pm
134 Views
Post# 29230357

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:LOL - Sweet news release team -4%

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:LOL - Sweet news release team -4%From the MD&A dated Oct. 30, 2108:

The Laval Facility is currently 10,000 square feet and Sublime expects to increase its size
to 37,000 square feet if the Company decides to invest in the completion of the second phase of the Laval Facility (“Phase Two”). The Phase Two build out is estimated to cost between $10 million and $15 million. Phase Two construction will not commence until the Company secures funding for the project and Sublime receives its cultivation license from Health Canada for Phase One."

IMO, MYM has been upfront and transparent with their plans to expand Laval.  Funding for the expansion has been secured from Alumina.  Everything is waiting for HC license decision.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities